923 results on '"Rivella, Stefano"'
Search Results
152. Potential Therapeutic Applications of Jak2 Inhibitors and Hif2a-ASO for the Treatment of β-Thalassemia Intermedia and Major
153. Genetic Investigation of the Role of GDF11 in the Treatment of β-Thalassemia and MDS
154. Adult Hemoglobin Production, Chain Rebalance, and Splice Correction in IVS2-745 Beta-Thalassemia Patient Cells Using 2'-O-Methoxyethyl Splice-Switching Oligos
155. A Novel Dual Monoclonal Sandwich ELISA for Human Erythroferrone
156. Ex Vivo Gene Therapy Approach By Targt Technology for the Treatment of β-Thalassemia Intermedia
157. Lack of hepcidin ameliorates anemia and improves growth in an adenine-induced mouse model of chronic kidney disease
158. Recent trends in the gene therapy of β-thalassemia
159. A validated THALAMOSS cellular biobank for β-thalassemia
160. Generation and characterization of a transgenic mouse carrying a functional human ?-globin gene with the IVSI-6 thalassemia mutation
161. Beta-1 Integrin Controls Homing and Expansion of Erythroid Cells in Stress Erythropoiesis and beta-Thalassemia
162. Management of non‐transfusion‐dependent β‐thalassemia (NTDT): The next 5 years.
163. Revisiting the non‐transfusion‐dependent (NTDT) vs. transfusion‐dependent (TDT) thalassemia classification 10 years later.
164. Phenotypic HSPC Rescue By RNA Lipid Nanoparticles in a Murine Model of Fanconi Anemia
165. Differential Effect of Transferrin Lobe Iron Occupancy on a Murine Model of Inflammation
166. Differential Effects of Monoferric Transferrin Forms on Erythropoiesis Are Mediated By TFR2
167. Chapter 38 - Thalassemia Syndromes
168. A validated cellular biobank for β-thalassemia
169. Abstract 1232: A-type proanthocyanidins selectively target acute myeloid leukemia cells in vitro and in vivo
170. Down-Regulation of TfR1 Increases Erythroid Precursor Enucleation and Hepatocyte Hepcidin Expression in ß-Thalassemic Mice
171. Targeting TMPRSS6 Using Antisense Technology for the Treatment of Beta-Thalassemia
172. A Double Knock out of Hepcidin and IL6 Demonstrates Independent Roles of the Two Genes in Anemia of Inflammation
173. Lack of Beta-1 Integrin Limits Stress Erythropoiesis and Splenomegaly in Beta-Thalassemia
174. Lack of Gdf11 does not improve anemia or prevent the activity of RAP-536 in a mouse model of ß-thalassemia
175. Lack of Gdf11does not improve anemia or prevent the activity of RAP-536 in a mouse model of β-thalassemia
176. Decreased hepcidin expression in murine β-thalassemia is associated with suppression of Bmp/Smad signaling
177. Myeloid cell-derived HIF attenuates inflammation in UUO-induced kidney injury
178. Generation of New Cell Models to Screen Improved Vectors for Functional Hemoglobin Expression
179. Absence of Interleukin-6 Protects Murine Bone Marrow Erythropoiesis Under Inflammation, in a Process Reversible By Iron Mediated Reactive Oxygen Species Upregulation
180. Influential Role of Macrophages in Hepcidin Regulation in Apo-Transferrin Treated β-Thalassemic Mice
181. Iron Binding to Specific Lobes of Transferrin Differentially Affects Erythropoiesis and Hepcidin Signaling
182. Intestine-specific Disruption of Hypoxia-inducible Factor (HIF)-2α Improves Anemia in Sickle Cell Disease
183. Recent trends in the gene therapy of β-thalassemia
184. Alternative splicing of EKLF/KLF1 in murine primary erythroid tissues
185. Generation and Characterization of a Transgenic Mouse Carrying a Functional Humanβ-Globin Gene with the IVSI-6 Thalassemia Mutation
186. A preclinical approach for gene therapy of beta-thalassemia
187. 𝛽 -Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload
188. Increased Hepcidin Expression in β-Thalassemic Mice Treated with Apo-Transferrin Is Associated with Increased Smad1/5/8 and Decreased Erk1/2 Pathway Activation
189. Concurrent Treatment with Minhepcidin and Deferiprone Improves Anemia and Enhances Reduction of Spleen Iron in a Mouse Model of Non-Transfusion Dependent Thalassemia
190. Comparing Strategies to Reactivate Fetal Globin Expression for the Treatment of Beta-Globinopathies
191. Combination of Tmprss6-ASO and the Iron Chelator Deferiprone Improves Erythropoiesis and Reduces Iron Overload in a Mouse Model of Beta-Thalassemia
192. Exogenous Apo-Transferrin Increases Monoferric Transferrin, Decreasing Cytosolic Iron Uptake and Heme and Globin Synthesis in β-Thalassemic Mice
193. Stress Erythropoiesis Is Associated with Changes in the Transcriptome of Central Macrophages
194. Use of Minihepcidins As a “Medical Phlebotomy” in the Treatment of Polycythemia Vera
195. Beta-1 Integrin Controls Homing and Expansion of Erythroid Cells in Stress Erythropoiesis and ß-Thalassemia
196. Iron age: novel targets for iron overload
197. Altered erythropoiesis and iron metabolism in carriers of thalassemia
198. Corrigendum to “β-Thalassemia and polycythemia vera: Targeting chronic stress erythropoiesis” [Int. J. Biochem. Cell Biol. 51 (2014) 89–92]
199. Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β°39 thalassemia patients
200. In Vivo Modification of Hematopoietic Stem Cells By Targeted Lipid Nanoparticles Encapsulating mRNA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.